Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 14 dokumen yang sesuai dengan query
cover
Ambari
"Telah dibuat suatu Sistem Kendali dan Pemroses Alat Pengumpul Data Pemilih Secara Elektronik Di Dalam Pemilu Presiden dengan menggunakan Microcontroller ,yang dapat
digunakan kpu (komisi pemilihan umum) sebagai sarana perhitungan suara pada pemilihan umum presiden, kelebihannya adalah dapat mengurangi biaya operasional karena sistem tidak
menggunakan kertas dan menconterengnya cukup menekan tombol yang disediakan dan nama kandidat presiden dapat dilihat pada layar LCD. Buzzer akan berbunyi sebagai indikator bahwa
pemilih sudah melakukan hak pilihnya dan hasilnya akan di display ketika semua pemilih sudah melaukan hak pilihnya. Waktu yang dibutuhkan untuh memilih juga ralatif singkat karena tidah perlu melipat-lipat lagi kertas

Has created a Full System and Processing Equipment Electronic Voter Data Collector In
The Presidential Election by using the microcontroller, which can be used in the General
Elections Commission (electoral commission) as a means of calculation of votes in presidential
elections, the excess is able to reduce operating costs because the system does not use paper and
menconterengnya simply press the button provided and the name of the presidential candidates
can be viewed on the LCD screen. Buzzer will sound as an indicator that the voters had done the
right vote and the results will be displayed when all voters have melaukan vote. Time required untuh choose ralatif also brief because tidah-fold longer need to fold the paper
"
Depok: Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Indonesia, 2010
TA-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Marlina
"Latar belakang: Pneumonia adalah salah satu masalah kesehatan utama pada geriatri. Proses penuaan sistem organ dan faktor komorbid banyak berperan pada peningkatan morbiditas dan mortalitas pneumonia pada pasien geriatri sehingga menyebabkan tingginya biaya pengobatan penyakit tersebut. Salah satu biaya yang menyerap besar anggaran rumah sakit adalah biaya antibiotik. Tingginya biaya penggunaan antibotik untuk pneumonia komunitas menyebabkan perlunya dilakukan analisis farmakoekonomi. Cost effectiveness adalah salah satu metode analisis farmakoekonomi.
Tujuan: Menilai cost effectiveness tata laksana pneumonia komunitas pada geriatri.
Metode: Penelitian ini dilakukan secara retrospektif pada pasien geriatri rawat inap dengan pneumonia komunitas di RSCM periode 1 Januari 2012-31 Maret 2016. Analisis cost effectiveness digunakan untuk analisis farmakoekonomi yang membandingkan biaya (cost) dengan hasil luaran klinis sembuh (effectiveness).
Hasil: Sebanyak 104 pasien geriatri dengan pneumonia komunitas dirawat di RSCM dianalisis cost effectiveness dan dikelompokkan menjadi 5 kelompok yaitu: kombinasi seftriakson azitromisin (n=38), kombinasi sefotaksim azitromisin (n=23), monoterapi meropenem (n=22), kombinasi meropenem levofloksasin (n=13), dan monoterapi sefepim (n=8). Kesembuhan tertinggi pada monoterapi sefepim (100%), kombinasi sefotaksim azitromisin (95,7%), dan kombinasi seftriakson azitromisin (92,1%). Kematian tertinggi pada kombinasi meropenem levofloksasin (46,2%) dan monoterapi meropenem (36,4%). Penelitian ini dibagi menjadi 2 kelompok besar. Kelompok 1 terdiri dari kombinasi seftriakson azitromisin dan kombinasi sefotaksim azitromisin. Kelompok 2 terdiri dari kombinasi meropenem levofloksasin, monoterapi meropenem dan monoterapi sefepim. Nilai ACER (Average Cost Effectiveness Ratio) pada kombinasi seftriakson azitromisin Rp285.097,- dan monoterapi sefepim memiliki nilai ACER Rp 1.747.356,-. Pada nilai ICER (Intremental Cost Effectivenees Ratio), penggunaan kombinasi seftriakson azitromisin memberikan selisih penambahan harga sebesar Rp 31.756,- untuk setiap selisih penambahan 1% kesembuhan dibandingkan dengan kombinasi sefotaksim azitromisin. Penggunaan monoterapi sefepim memberikan selisih penurunan harga sebesar Rp 58.124,- untuk setiap selisih penambahan 1% kesembuhan dibandingkan dengan monoterapi meropenem. Penggunaan monoterapi sefepim memberikan selisih penurunan harga sebesar Rp 83.918,- untuk setiap selisih penambahan 1% kesembuhan dibandingkan dengan kombinasi meropenem levofloksasin. Penggunaan meropenem memberikan selisih penurunan harga sebesar Rp 179.724,- untuk setiap selisih penambahan 1% kesembuhan dibandingkan dengan kombinasi meropenem levofloksasin untuk terapi pneumonia komunitas pada geriatri.
Kesimpulan: Kedua rejimen antibiotik kombinasi seftriakson azitromisin dan kombinasi sefotaksim azitromisin memiliki cost effectiveness yang sama untuk terapi pneumonia komunitas pada geriatri. Monoterapi sefepim memiliki cost effectiveness lebih tinggi dibandingkan monoterapi meropenem dan kombinasi meropenem levofloksasin untuk terapi pneumonia komunitas pada geriatri.

Background: Pneumonia is one of the major health problems in elderly. The aging process of organ systems and many comorbid factors contribute to increase the morbidity and mortality of pneumonia in geriatric patients, causing high costs of the treatment, mainly the cost of antibiotic. The high cost of antibiotic used for community pneumonia creates need for pharmacoeconomics analysis. Cost effectiveness analysis is one of the method for doing pharmacoeconomics analysis.
Objective: To analyze the cost effectiveness of antibiotic uses on community pneumonia in elderly.
Method: This study was conducted retrospectively in hospitalized geriatric patients with community pneumonia in RSCM for period of 1 January 2012-31 March 2016. The cost effectiveness analysis method was used to analyze pharmacoeconomics by comparing the expense (cost) with clinically cured patients (effectiveness).
Result: A total of 104 geriatric patients with community pneumonia treated in RSCM were analyzed by using cost effectiveness method. They were classified into 5 groups: combination of azithromycin ceftriaxone+azithromycin (n=23), combination of cefotaxime+azithromycin (n=38), meropenem monotherapy (n=22), combination of meropenem+levofloxacin (n=13), and cefepime monotherapy (n=8). The highest percentage of recovery was found in cefepime monotherapy (100%), followed by combination of cefotaxime+azithromycin (95.7%) and combination of ceftriaxone+azithromycin (92.1%). The highest percentage of mortality was observed in the combination of meropenem+ levofloxacin (46.2%), followed by meropenem monotherapy (36.4%). This research is divided into two large groups. Group 1 consisted of combination of ceftriaxone+azithromycin and combination of cefotaxime+azithromycin. Group 2 consisted of combination of meropenem+levofloxacin, meropenem monotherapy and cefepime monotherapy .The Average Cost Effectiveness Ratio of combination ceftriaxone+azithromycin is Rp 285.097,-while the ACER of cefepime monotherapy is Rp 1.747.356,-. The Intremental Cost Effectivenees Ratio of combination of ceftriaxone+azithromycin is Rp 31.756,- for each 1% increment of recovery when compared to combination of cefotaxime+azithromycin. The use of cefepime monotherapy provides reduction of Rp 58.124, - for each 1% additional of recovery compared to meropenem monotherapy. The use of cefepime monotherapy provides reduction of Rp 83.918,- for each 1% additional of recovery compared to combination of meropenem+levofloxacin. The use of meropenem provides reduction of Rp 179.724,- for each 1% additional of recovery compared to combination of meropenem+levofloxacin for treatment of community pneumonia in elderly.
Conclusions: Both of two regimen azithromycin+ceftriaxone and cefotaxime+azithromycin got the same cost of effectiveness for the treatment of community pneumonia in elderly. Cefepime monotherapy has higher cost effectiveness than meropenem monotherapy and combination of meropenem+levofloxacin for treatment of community pneumonia in elderly.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2016
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Asep Saepul Rahmat
"Latar belakang. Studi pH lambung pada pasien sirosis hati masih kontroversi Penelitian ini bertujuan untuk mengetahui adanya perbedaan pH lambung pada pasien sirosis hati dengan gastropati hipertensi portal GHP ringan dan berat.
Metode Penelitian. Potong lintang dengan cara konsekutif pada pasien yang datang ke poliklinik gastro enterologi dan hepatologi RSCM pada periode Maret - Mei 2014 sebanyak enam puluh dua pasien sirosis hati dengan GHP dilakukan pemeriksaan endoskopi untuk menilai derajat gastropati sesuai klasifikasi McCormack dan pemeriksa pH lambung dengan menggunakan pH meter.
Hasil. Dari 62 subjek didapatkan 50 subjek 80 6 berjenis kelamin laki laki dan perempuan 12 subjek 19 4 GHP paling banyak disebabkan oleh hepatitis C 56 5 hepatitis B 32 3 non hepatitis 8 1 dan alkohol 3 2 Rerata pH lambung pada seluruh pasien sirosis hati dengan GHP adalah 2 13 Rerata pH lambung pada pasien sirosis hati dengan GHP ringan 2 00 lebih rendah dibandingkan kelompok GHP berat 2 25 dengan perbedaan yang bermakna.

Background. Studies show gastric pH in cirrhosis patient still in controversy Aim of this study to know differences of gastric pH in liver cirrhosis patient withmild and severe portal hypertensive gastropathy
Methods. Cross sectional method with consecutive to all liver cirrhotic patientwho came to gastroenterology and hepatology clinic in Ciptomangunkusumo hospital Sixty two liver cirrhosis patients with portal hypertensive gastropathyunderwent endoscopy to measure degree of gastropathy based on McCormack classification and measured mean basal gastric pH with pH metry.
Result. There are 50 male subject 80 6 and 12 female subject 19 4 participating in this research Portal hypertensive gastropathy mostly caused by hepatitis C 56 5 hepatitis B 32 3 non hepatitis 8 1 and alcohol 3 2 Mean of gastric pH in all liver cirrhosis patient with portal hypertensive gastropathy was 2 13. The mean gastric pH in liver cirrhosis patient with mildportal hypertensive gastropathy 2 00 mEq L lower than the gastric pH in severeportal hypertensive gastropathy 2 25 mEq L with significant differences.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2014
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Kaka Renaldi
"ABSTRAK
Latar belakang: Sejak tahun 1980 Divisi Gastroenterologi Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia/Rumah Sakit Cipto Mangunkusumo (IPD FKUI/RSCM) membuat kriteria derajat gastritis kronik berdasarkan gambaran esofagogastroduodenoskopi (EGD) adanya hiperemis dan erosi. Kriteria derajat gastritis kronik ini banyak digunakan di seluruh Indonesia namun kriteria tersebut belum pernah dilakukan uji diagnostik.
Tujuan: Mendapatkan akurasi diagnostik derajat gastritis kronik berdasarkan pemeriksaan EGD dibandingkan dengan pemeriksaan histopatologi.
Metode: Penelitian ini merupakan uji diagnostik derajat gastritis kronik berdasarkan hasil pemeriksaan EGD pada pasien yang memiliki indikasi, dibandingkan dengan gambaran histopatologi sebagai pemeriksaan baku emas yang dilakukan di Pusat Endoskopi Saluran Cerna (PESC) Divisi Gastroenterologi Departemen IPD FKUI/RSCM dari Oktober 2014 hingga Februari 2015. Uji diagnostik yang dilakukan ada 2 yaitu uji diagnostik gastritis sedang - ringan dan berat - sedang. Masing-masing uji diagnostik di atas, ditampilkan parameter-parameter uji diagnostik berupa sensitivitas (Se), spesifisitas (Sp), nilai duga positif (NDP), nilai duga negatif (NDN), serta rasio kemungkinan (RK) positif dan negatif. Seluruh parameter di atas menyertakan interval kepercayaan 95% (IK 95%).
Hasil Penelitian: Dari 230 subjek didapatkan karateristik penelitian perempuan lebih banyak dari laki - laki dengan perbandingan 3:2, terdapat merata pada semua kelompok usia, DM 23%, hipertensi 36,5% dan infeksi H.pylori 2,6%. Hasil uji diagnostik gastritis ringan - sedang: Se 0.95 (IK 95% 0.87-0.98), Sp 0.96 (IK 95% 0.86-0.99), NDP 0.97 (IK 95% 0.89-0.99), NDN 0.94 (IK 95% 0.84-0.98), RK Positif 23.39 (IK 95% 6.09- 89.74) dan RK Negatif 0.05 (CI 95% 0.02-0.14). Hasil uji diagnostik gastritis sedang - berat: Sensitivitas 0.93 (IK 95% 0.82-0.98), Spesifisitas 0.94 (IK 95% 0.86-0.98), Nilai Duga Positif 0.91 (IK 95% 0.79-0.96), Nilai Duga Negatif 0.96 (IK 95% 0.88-0.99), Rasio Kemungkinan Positif 16.54 (IK 95% 6.32-43.28) dan Rasio Kemungkinan Negatif 0.05 (CI 95% 0.02-0.21).
Kesimpulan: Pemeriksaan EGD memiliki akurasi yang baik untuk menegakkan diagnosis derajat gastritis kronik.

ABSTRACT
Background: Since 1980, Division of Gastroenterology Department of Internal Medicine FKUI/RSCM had made a criteria for chronic gastritis grading based on hyperemic and erosion that are found in gastric?s mucosa based on esophagogastroduodenoscopy (EGD) examination. This criteria is used nationwide all over Indonesia but until now there is no diagnostic study for chronic gastritis grading based on EGD examination compare to histopathology examination as the gold standard.
Purpose: To get diagnostic accuracy of chronic gastritis grading based on EGD compared to histopathology.
Methods: This research is a diagnostic study about chronic gastritis grading by EGD from patients that had indication for, compared to histophatology as a gold standard in gastrointestinal endoscopy room Division of Gastroenterology Department of Internal Medicine FKUI/RSCM from October 2014 to February 2015. There will be 2 diagnostic study, mild to moderate gastritis and severe to moderate gastritis diagnostic study. For every diagnostic study, the parameters that will be showed are Sensitivity (Se), Specificity (Sp), Possitive Predictive Value (PPV), Negative Predictive Value (NPV), Possitive Likelihood Ratio and Negative Likelihood Ratio (NLR). The 95% confidence interval will be included.
Results: Of 230 subjects, there were more women than men with ratio 3:2, age didn?t affect the grading of chronic gastritis, type 2 diabetes was found in 23% patients, hypertension was found in 36,5% patients and H.pylori infection in only 2.6% patients. The results for mild to moderate gastritis : Sensitivity 0.95 (CI 95% 0.87-0.98), Specificity 0.96 (CI 95% 0.86-0.99), Possitive Predictive Value 0.97 (CI 95% 0.89- 0.99), Negative Predictive Value 0.94 (CI 95% 0.84-0.98), Possitive Likelihood Ratio 23.39 (CI 95% 6.09-89.74), and Negative Likelihood Ratio 0.05 (CI 95% 0.02-0.14). The results for moderate to severe gastritis : Sensitivity 0.93 (CI 95% 0.82-0.98), Specificity 0.94 (CI 95% 0.86-0.98), Possitive Predictive Value 0.91 (CI 95% 0.79-0.96), Negative Predictive Value 0.96 (CI 95% 0.88-0.99), Possitive Likelihood Ratio 16.54 (CI 95% 6.32-43.28), and Negative Likelihood Ratio 0.05 (CI 95% 0.02-0.21).
Conclusion: Esophagogastroduodenoscopy feature has good accuracy to diagnose the grading of chronic gastritis.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2015
T58689
UI - Tesis Membership  Universitas Indonesia Library
cover
Griskalia Christine
"Latar Belakang: Diffuse Large B-cell Lymphoma (DLBCL) merupakan limfoma tersering di Indonesia. Kemoterapi R-CHOP mempunyai risiko moderat untuk terjadinya neutropenia / demam neutropenia. Limfosit dapat menggambarkan imunitas pejamu, sedangkan neutrofil dan monosit dapat menggambarkan respons inflamasi. Belum ada penelitian yang menilai hitung jenis leukosit sebagai prediktor neutropenia akut awitan pertama pascakemoterapi R-CHOP pada pasien DLBCL.
Tujuan: Mengetahui hubungan parameter hitung jenis leukosit sebelum kemoterapi sebagai prediktor neutropenia akut awitan pertama pascakemoterapi R-CHOP pada pasien DLBCL.
Metode: Kohort retrospektif di RSUPN. Cipto Mangunkusumo. Pasien DLBCL 18-60 tahun, ECOG 0-1, tanpa komorbid yang berhubungan dengan kemoterapi, yang dilakukan kemoterapi R-CHOP 3 siklus pertama tanpa profilaksis G-CSF.
Hasil: Dari 95 pasien, neutropenia akut awitan pertama pascakemoterapi terjadi pada 83 (87,4%) subjek atau 83 (55,3%) siklus dari total 150 siklus kemoterapi. Demam neutropenia terjadi pada 50,6% dari awitan neutropenia. Neutropenia berat terjadi pada 34 (41,0%) siklus dari 83 episode neutropenia. Neutropenia akut awitan pertama paling sering terjadi pada 7-15 hari pascakemoterapi.
Rasio neutrofil limfosit mempunyai AUROC 0,74 (IK 95% 0,6-0,82); sedangkan limfosit absolut, neutrofil absolut, monosit absolut, dan rasio limfosit monosit mempunyai AUROC <0,70. Rasio neutrofil limfosit > 4,1 dapat memprediksi neutropenia akut awitan pertama pascakemoterapi RCHOP pada pasien DLBCL (sensitivitas 71,1%; spesivisitas 64,2%; nilai duga positif 71,1%; dan nilai duga negatif 64,2%).

Background: Diffuse Large B-cell Lymphoma (DLBCL) is the most common lymphoma in Indonesia. R-CHOP chemotherapy has a moderate risk for neutropenia / febrile neutropenia. Lymphocytes can describe host immunity, while neutrophils and monocytes can describe the inflammatory response. No study has assessed differential count of leukocytes as a predictor of the first onset acute neutropenia after R-CHOP chemotherapy in DLBCL patients.
Objective: To determine the relationship between differential count of leukocytes before chemotherapy as a predictor of the first onset acute neutropenia after R-CHOP chemotherapy in DLBCL patients.
Methods: Retrospective cohort in RSUPN. Cipto Mangunkusumo. DLBCL patients 18-60 years old, ECOG 0-1, no comorbidity related to chemotherapy. Subjects were given with the first 3 cycles of R-CHOP chemotherapy without G-CSF prophylaxis.
Results: Of the 95 patients, first onset acute neutropenia after chemotherapy occurred in 83 (87.4%) subjects or 83 (55.3%) cycles of 150 chemotherapy cycles. Febrile neutropenia occurs in 50,6% of the onset of neutropenia. Severe neutropenia occurs in 34 (41.0%) cycles of 83 neutropenic episodes. The first onset of acute neutropenia is most common at 7-15 days after chemotherapy.
The neutrophil lymphocyte ratio has AUROC 0.74 (95% CI 0.65-0.82); while absolute lymphocytes, absolute neutrophils, absolute monocytes, and monocyte lymphocyte ratios have AUROC <0.70. The neutrophil lymphocyte ratio > 4.1 can predict the first onset of acute neutropenia after RCHOP chemotherapy in DLBCL patients (sensitivity 71.1%; specificity 64.2%; positive predictive value 71.1%; negative predictive value 64.2%).
Conclusion: The neutrophil lymphocyte ratio before chemotherapy > 4.1 has moderate performance in predicting the first onset of acute neutropenia post R-CHOP chemotherapy in DLBCL patients. Absolute lymphocytes count, monocytes count, neutrophils count, and monocyte lymphocyte ratio cannot be used as a predictor of the first onset acute neutropenia post R-CHOP chemotherapy in DLBCL patients.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2019
T58838
UI - Tesis Membership  Universitas Indonesia Library
cover
Gestana Andru
"Latar Belakang. Gangguan tidur sering dijumpai pada penyakit autoimun seperti lupus eritematosus sistemik (LES). Tidur yang buruk berdampak pada kualitas hidup yang rendah serta eksaserbasi akut dari inflamasi akibat LES. Penelitian mengenai kualitas tidur yang buruk pada pasien LES serta faktor - faktor yang berhubungan di Indonesia masih terbatas.
Tujuan. Mengetahui proporsi kualitas tidur yang buruk pada pasien LES di Rumah Sakit Umum Pusat Nasional dr. Cipto Mangunkusumo (RSCM) dan mengetahui faktor-faktor yang berhubungan.
Metode. Metode yang digunakan adalah studi potong lintang, melibatkan 166 subjek LES berusia minimal 18 tahun yang berobat ke poliklinik Alergi Imunologi RSCM sejak Januari 2019. Subjek mengisi secara mandiri kuesioner kualitas tidur menggunakan Pittsburgh Sleep Quality Index(PSQI) dan kuesioner gejala depresi dan ansietas menggunakan Hospital Anxiety Depression Scale(HADS). Skala nyeri dinilai mengggunakan Visual Analogue Scale(VAS), aktivitas penyakit LES dinilai menggunakan Systemic Lupus Erythematosus Disease Activity Index 2000(SLEDAI-2K). Subjek menjalani pemeriksaan imbalans otonom yang dinilai menggunakan rasio Low Frequency/High Frequency (LF/HF) dari Heart Rate Variability(HRV), dan pemeriksaan kadar high sensitivity C-Reactive Protein(hs-CRP).Analisis bivariat menggunakan uji Chi Squaredan analisis multivariat menggunakan regresi logistik.
Hasil. Rerata untuk skor PSQI global pada 166 subjek sebesar 9,36 (3,61) dengan proporsi kualitas tidur buruk sebanyak 82,5%. Pada analisis bivariat didapatkan dua variabel dengan hubungan bermakna dengan kualitas tidur yang buruk yaitu gejala depresi (OR: 5,95; p: 0,03) dan gejala ansietas (OR: 2,44; p: 0,05). Regresi logistik tidak menunjukkan variabel dengan hubungan bermakna dengan kualitas tidur yang buruk.
Simpulan.Proporsi kualitas tidur buruk pada pasien LES sebesar 82,5%. Tidak terdapat faktor yang berhubungan dengan kualitas tidur buruk pada LES.

Background. Sleep disturbances are often seen in systemic lupus erythematosus (SLE). Poor sleep will lead to poor quality of life and frequent exacerbations of SLE. However, studies about poor sleep quality in SLE patients as well as the contributing factors are limited.
Objectives. The aim of this study is to determine the proportion of poor sleep quality in SLE patients in Cipto Mangunkusumo National General Hospital (RSCM) and to assess its contributing factors.
Methods. This study used a cross sectional design involving 166 subjects of SLE patients from Immunology clinic since January 2019. The Pittsburgh Sleep Quality Index was used to assess sleep quality of subjects. Depression and anxiety symptoms was assesed using the Hospital Anxiety Depression Scale (HADS). Pain scale was assesed using Visual Analogue Scale (VAS) and SLE activity was assessed using Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K). Autonomic imbalance was assesed using Low Frequency/High Frequency(LF/HF) ratio from Heart Rate Variability(HRV), and subjects went through high sensitivity C-Reactive Protein(hs-CRP) test. Bivariate analysis using Chi Square test and multivariate analysis using logistic regression.
Result.The mean global score for the PSQI among 166 subjects was 9,36 (3,61). The proportion of poor sleep quality was 82.5%. There were two variables with significant association including depressive symptoms (OR 5.95; p 0.03) and anxiety symptoms (OR 2.44; p 0.05). There were no variable with significant association through logistic regression.
Conclusion. The proportion of poor sleep quality from SLE patients in RSCM was 82.5%. This study did not find any factors associated with poor sleep quality in SLE patients.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2019
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Amanda Pitarini Utari
"Pendahuluan: Konstipasi kronik merupakan masalah kesehatan yang memiliki dampak signifikan dari segi kualitas hidup dan sosioekonomi. Studi konstipasi kronik menggunakan kriteria baku belum pernah dilakukan di Indonesia. Penelitian ini bertujuan untuk menilai kejadian konstipasi di populasi dewasa Indonesia serta faktor-faktor yang berhubungan.
Metode: Penelitian ini menggunakan disain potong lintang yang dilakukan di komunitas sebagai bagian dari Global Epidemiology Study on Functional Gastrointestinal Disorders. Subjek diminta menjawab pertanyaan kuesioner dengan bantuan pewawancara yang telah mendapat pelatihan. Sejumlah 2000 orang subjek dikumpulkan dari kawasan urban dan rural di Indonesia. Konstipasi kronik ditegakkan menurut kriteria Rome IV yang telah divalidasi. Analisis multivariat dilakukan terhadap faktor yang berhubungan dengan konstipasi kronik.
Hasil: Penelitian ini mengevaluasi 1935 subjek yang memenuhi kriteria inklusi. Prevalensi konstipasi kronik di populasi dewasa di Indonesia adalah 12,3%. Kawasan urban (OR 0,472, p<0,001) dan jenis kelamin wanita (OR 2,67, p<0,001) berhubungan dengan konstipasi kronik di populasi dewasa di Indonesia. Usia, indeks massa tubuh, dan tingkat Pendidikan ditemukan tidak berhubungan dengan konstipasi kronik. Analisis lebih lanjut terhadap tingkat pendidikan di kawasan rural mendapatkan adanya hubungan yang bermakna secara statistik (OR 0,519, p<0,05) antara tingkat pendidikan rendah dan konstipasi kronik.
Kesimpulan: Prevalensi konstipasi kronik pada populasi dewasa di Indonesia adalah 12,3%. Kawasan urban dan jenis kelamin wanita merupakan faktor yang berhubungan dengan kejadian konstipasi kronik.

Introduction: Chronic constipation is a medical problem with significant quality of life reduction and socioeconomic impact. Chronic constipation study with validated criteria never been conducted in Indonesia. This study aim to find prevalence rate of chronic constipation and its associated factors in Indonesian adult population.
Methods: This was a population-based cross-sectional study and a part of Global Epidemiology Study on Functional Gastrointestinal Disorders. Subject answered questions from a questionnaire with the help of traineed-interviewers. A total of 2000 subjects were recruited from urban and rural area in Indonesia. Diagnosis of chronic constipation based on validated Rome IV criteria. Multivariat analysis was performed for associated factors with chronic constipation.
Results: There were 1935 subjects that enrolled in this study. The prevalence of chronic constipation in Indonesian adult population was 12.3%. Urban area (OR 0.472, p<0,001) and female (OR 2.67, p<0.05). Age, body mass index, and education level were not statistically significant factors associated with chronic constipation. Lower education level was associated with chronic constipation only in rural area (OR 0.519, p<0.05).
Conclusion: The prevalence of chronic constipation in Indonesian adult population was 12.3%. Urban area and female were factors associated with chronic constipation.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2019
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Azri Nurizal
"Latar Belakang: Peningkatan kadar high sensitivity C-reactive protein ( hsCRP ) dan kekakuan arteri berhubungan dengan peningkatan insiden kejadian kardiovaskular dan peningkatan mortalitas akibat penyakit jantung koroner pada pasien diabetes melitus tipe 2.
Tujuan: Tujuan dari penelitian ini adalah untuk mengetahui hubungan antara kadar hsCRP dan kekakuan arteri pada pasien diabetes melitus tipe 2.
Metode : Melalui studi cross-sectional, dilakukan pemeriksaan kadar hsCRP dan derajat kekakuan arteri karotis pada 40 pasien dengan diabetes melitus tipe 2. Kekakuan arteri karotis kommunis diperiksa dengan doppler echotracking system untuk menentukan pulse wave velocity (PWV) atau kekakuan arteri karotis lokal (carotid-PWV).
Hasil : Nilai median hsCRP pada penelitian ini adalah 4,5 (0,2 - 18,9) mg/L dan nilai rata-rata kekakuan arteri karotis adalah 8,8 ±1,7 m/detik. hsCRP berkorelasi kuat dengan karotid-PWV (r = 0,503, P = 0,001). Korelasi hsCRP dengan karotid-PWV ini tetap terlihat setelah dilakukan koreksi terhadap umur, indeks masa tubuh dan mean arterial pressure (r = 0,450, P = 0,005).
Kesimpulan : Setelah dilakukan koreksi terhadap umur, indeks masa tubuh dan mean arterial pressure, hsCRP berkorelasi positif cukup kuat dengan kekakuan arteri pada pasien diabetes melitus tipe 2.

Background: The elevated level of high-sensitivity C-reactive protein (hsCRP) and arterial stiffness are associated with higher incidences of cardiovascular events and with increased mortality from coronary heart disease in type 2 diabetic patients.
Aim: The aim of this study was to investigate the relationship between hsCRP and arterial stiffness in type 2 diabetic patients.
Methods: A cross-sectional study was conducted to assess the plasma levels of high sensitive C-reactive protein and carotid arterial stiffness among 40 patients with type 2 diabetes mellitus. The common carotid artery was studied by a doppler echotracking system to determine the local carotid pulse wave velocity (carotid-PWV).
Results: The median value of hsCRP in this study was 4.5 (0.2 to 18.9) mg/L and the average value of local carotid stiffness was 8.8 ± 1.7 m/sec. hsCRP showed a strong correlation with carotid-PWV (r = 0.503, P = 0.001). Levels of hsCRP were independently associated with carotid-PWV after adjusting for age, body mass index, and mean arterial pressure (r = 0,450, P = 0,005).
Conclusion: After adjusting for age, body mass index, and mean arterial pressure, hsCRP was strongly positively correlated with arterial stiffness in patients with type 2 diabets mellitus.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2014
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Wachid Putranto
"[ABSTRAK
Latar Belakang : Continous ambulatory peritoneal dialysis (CAPD) telah menjadi
alternatif selain hemodialisis untuk pengobatan penyakit ginjal tahap akhir. Fibrosis
peritoneum merupakan penyebab utama terjadinya kerusakan membran peritoneum.
Mekanisme fibrosis peritoneum belum diketahui secara pasti, namun ditengarai
transforming growth factor ? β (TGF ?β) berhubungan erat terhadap terjadinya fibrosis
peritoneum.
Tujuan : Tujuan penelitian ini adalah untuk mengetahui pengaruh kombinasi ACE
inhibitor (ACEI) dan calcium channel Blocker (CCB) terhadap penurunan ekspresi TGF
? β dan fibrosis peritoneum tikus jantan yang telah dilakukan CAPD.
Metode Penelitian : Penelitian eksperimental, post test only control group design. Tiga
puluh tikus Dawley spraque dibagi menjadi lima kelompok yaitu kelompok kontrol
(kelompok 1) dan kelompok perlakuan dengan pemberian masing-masing cairan CAPD
4,25% (kelompok2) lisinopril 1,44 mg oral dan CAPD (kelompok 3) diltiazem CD 6,48
mg oral dan CAPD (kelompok 4) lisinopril 1,44 mg dan diltiazem CD 6,48 mg oral dan
CAPD (kelompok 5). Setelah 4 minggu tikus dikorbankan dengan cara dislokasi cervical
kemudian diperiksa ekspresi TGF ? β dan terjadinya fibrosis pada peritoneum tikus,
selanjutnya dibuat sediaan histopatologi dan diwarnai dengan hematoksilin eosin serta
imunohistokimia menggunakan antihuman TGF-ß.
Hasil : Dua puluh peritoneum tikus berhasil diperiksa. Rerata skor TGF-β kelompok
kontrol 1,8, kelompok CAPD 2, kelompok lisinopril dan CAPD 1,8, kelompok diltiazem
CD dan CAPD 1,8, kelompok lisinopril dan diltiazem CD dan CAPD 1,7 (p=0,959).
Rerata skor fibrosis peritoneum kelompok kontrol 1,1, kelompok CAPD 2,6, kelompok
lisinopril dan CAPD 1,2, kelompok diltiazem CD dan CAPD 1,3, kelompok lisinopril dan
diltiazem CD dan CAPD1,5 (p=0,268)
Simpulan : Kombinasi lisinopril dan diltiazem mempunyai kecenderungan menurunkan
ekspresi TGF ? β lebih baik dibandingkan lisinopril maupun diltiazem yang diberikan
secara terpisah tetapi tidak bermakna secara statistik. Kombinasi lisinopril dan diltiazem
mempunyai kecenderungan mengurangi fibrosis peritoneum tetapi tidak bermakna secara
statistik dan tidak lebih baik dibandingkan lisinopril maupun diltiazem bila diberikan
secara terpisah.

ABSTRACT
Background : Continuous ambulatory peritoneal dialysis (CAPD) has been an
alternative other than hemodialysis for end stage kidney disease treatment.
Peritoneal fibrosis is the most serious cause of the damage in membrane
peritoneum. Mechanism of fibrosis peritoneum is not exactly known yet,
transforming growth factor ? β(TGF ? β) is closely related with the existence of
fibrosis peritoneum.
Purposes : The purpose of this study is to evaluate the effect of combination
between ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducing
expression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.
Research Method : Experimental study, post test only control group design.
Thirsty Dawley spraque rats are divided into five groups control group ( Group
1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)
diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD
6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression of
TGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosin
staining and immunology with anti human-TGF-β.
Result : Twenty peritoneal of rats can be examined. Mean score TGF-β control
group is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CD
and CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7
(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is
2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,
lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)
Summary : Combination of lisinopril and diltiazem lower the expression of TGF
? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically not
significant. Combination of lisinopril and diltiazem lower the peritoneal fibrosis
but statistically not significant and it doesn?t better than lisinopril or diltiazem.
Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been an
alternative other than hemodialysis for end stage kidney disease treatment.
Peritoneal fibrosis is the most serious cause of the damage in membrane
peritoneum. Mechanism of fibrosis peritoneum is not exactly known yet,
transforming growth factor ? β(TGF ? β) is closely related with the existence of
fibrosis peritoneum.
Purposes : The purpose of this study is to evaluate the effect of combination
between ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducing
expression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.
Research Method : Experimental study, post test only control group design.
Thirsty Dawley spraque rats are divided into five groups control group ( Group
1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)
diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD
6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression of
TGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosin
staining and immunology with anti human-TGF-β.
Result : Twenty peritoneal of rats can be examined. Mean score TGF-β control
group is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CD
and CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7
(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is
2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,
lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)
Summary : Combination of lisinopril and diltiazem lower the expression of TGF
? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically not
significant. Combination of lisinopril and diltiazem lower the peritoneal fibrosis
but statistically not significant and it doesn?t better than lisinopril or diltiazem.
Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been an
alternative other than hemodialysis for end stage kidney disease treatment.
Peritoneal fibrosis is the most serious cause of the damage in membrane
peritoneum. Mechanism of fibrosis peritoneum is not exactly known yet,
transforming growth factor ? β(TGF ? β) is closely related with the existence of
fibrosis peritoneum.
Purposes : The purpose of this study is to evaluate the effect of combination
between ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducing
expression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.
Research Method : Experimental study, post test only control group design.
Thirsty Dawley spraque rats are divided into five groups control group ( Group
1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)
diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD
6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression of
TGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosin
staining and immunology with anti human-TGF-β.
Result : Twenty peritoneal of rats can be examined. Mean score TGF-β control
group is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CD
and CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7
(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is
2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,
lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)
Summary : Combination of lisinopril and diltiazem lower the expression of TGF
? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically not
significant. Combination of lisinopril and diltiazem lower the peritoneal fibrosis
but statistically not significant and it doesn?t better than lisinopril or diltiazem.
Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been an
alternative other than hemodialysis for end stage kidney disease treatment.
Peritoneal fibrosis is the most serious cause of the damage in membrane
peritoneum. Mechanism of fibrosis peritoneum is not exactly known yet,
transforming growth factor ? β(TGF ? β) is closely related with the existence of
fibrosis peritoneum.
Purposes : The purpose of this study is to evaluate the effect of combination
between ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducing
expression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.
Research Method : Experimental study, post test only control group design.
Thirsty Dawley spraque rats are divided into five groups control group ( Group
1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)
diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD
6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression of
TGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosin
staining and immunology with anti human-TGF-β.
Result : Twenty peritoneal of rats can be examined. Mean score TGF-β control
group is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CD
and CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7
(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is
2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,
lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)
Summary : Combination of lisinopril and diltiazem lower the expression of TGF
? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically not
significant. Combination of lisinopril and diltiazem lower the peritoneal fibrosis
but statistically not significant and it doesn?t better than lisinopril or diltiazem.
Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.;Background : Continuous ambulatory peritoneal dialysis (CAPD) has been an
alternative other than hemodialysis for end stage kidney disease treatment.
Peritoneal fibrosis is the most serious cause of the damage in membrane
peritoneum. Mechanism of fibrosis peritoneum is not exactly known yet,
transforming growth factor ? β(TGF ? β) is closely related with the existence of
fibrosis peritoneum.
Purposes : The purpose of this study is to evaluate the effect of combination
between ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducing
expression of TGF ? β and fibrosis peritoneum in a male rat treated with CAPD.
Research Method : Experimental study, post test only control group design.
Thirsty Dawley spraque rats are divided into five groups control group ( Group
1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)
diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD
6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression of
TGF ? β and peritoneal fibrosis are conducted by histopatology with hematoxillineosin
staining and immunology with anti human-TGF-β.
Result : Twenty peritoneal of rats can be examined. Mean score TGF-β control
group is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CD
and CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7
(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is
2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,
lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)
Summary : Combination of lisinopril and diltiazem lower the expression of TGF
? β and fibrosis peritoneum better than lisinopril or diltiazem but statistically not
significant. Combination of lisinopril and diltiazem lower the peritoneal fibrosis
but statistically not significant and it doesn?t better than lisinopril or diltiazem.
Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis., Background : Continuous ambulatory peritoneal dialysis (CAPD) has been an
alternative other than hemodialysis for end stage kidney disease treatment.
Peritoneal fibrosis is the most serious cause of the damage in membrane
peritoneum. Mechanism of fibrosis peritoneum is not exactly known yet,
transforming growth factor – β(TGF – β) is closely related with the existence of
fibrosis peritoneum.
Purposes : The purpose of this study is to evaluate the effect of combination
between ACE inhibitor (ACEI) dan Calcium channel blocker (CCB) in reducing
expression of TGF – β and fibrosis peritoneum in a male rat treated with CAPD.
Research Method : Experimental study, post test only control group design.
Thirsty Dawley spraque rats are divided into five groups control group ( Group
1), CAPD liquid 4,25% (group 2), lisinopril 1,44 mg oral and CAPD (group 3)
diltiazem CD 6,48 mg oral and CAPD (group 4) lisinopril 1,44mg + diltiazem CD
6,48 mg oral and CAPD (group 5). After 4 weeks, rats sacrificed. Expression of
TGF – β and peritoneal fibrosis are conducted by histopatology with hematoxillineosin
staining and immunology with anti human-TGF-β.
Result : Twenty peritoneal of rats can be examined. Mean score TGF-β control
group is 1,8, CAPD group is 2, lisinopril and CAPD group is 1,8,diltiazem CD
and CAPD group is 1,8, lisinopril and diltiazem CD and CAPD group is 1,7
(p=0,959) .Mean score peritoneal fibrosis control group is 1,1, CAPD group is
2,6, lisinopril and CAPD group is 1,2, diltiazem CD and CAPD group is 1,3,
lisinopril and diltiazem CD and CAPD group is 1,5 (p=0,268)
Summary : Combination of lisinopril and diltiazem lower the expression of TGF
– β and fibrosis peritoneum better than lisinopril or diltiazem but statistically not
significant. Combination of lisinopril and diltiazem lower the peritoneal fibrosis
but statistically not significant and it doesn’t better than lisinopril or diltiazem.
Key words: ACE inhibitor, calcium channel blocker, TGF-β, peritoneal fibrosis.]"
2016
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Agus Joko Susanto
"Latar belakang: Tungau debu rumah TDR merupakan alergen hirup yang penting pada asma alergik. Namun, penelitian diagnostik molekuler menggunakan Imunoglobulin E IgE spesifik akibat sensitisasi alergen TDR dihubungkan dengan derajat keparahan asma alergik belum pernah dilakukan di Indonesia.
Tujuan: Mengetahui perbedaan kadar IgE spesifik serum kuantitatif akibat sensitisasi alergen Dermatophagoides D. pteronyssinus, D. farinae dan Blomia B. tropicalis pada asma alergik intermiten dan persisten.
Metode: Desain penelitian potong lintang pada pasien asma alergik dewasa yang diundang untuk pemeriksaan IgE spesifik serum dan merupakan bagian dari penelitian payung di Divisi Alergi dan Imunologi Klinik, RS Cipto Mangunkusumo. Derajat keparahan asma ditentukan berdasarkan kriteria Global Initiative on Asthma GINA 2015 dan dikelompokkan menjadi intermiten dan persisten. Pemeriksaan IgE spesifik serum kuantitatif menggunakan metode multiple allergosorbent test Polycheck Allergy, Biocheck GmbH, Munster, Germany . Alergen TDR yang diperiksa adalah D. pteronyssinus, D. farinae, dan B. tropicalis. Perbedaan antara dua kelompok dianalisis dengan uji Mann-Whitney.
Hasil: Sebanyak 87 subyek dilibatkan dalam penelitian ini; 69 79,3 subyek adalah perempuan. Rerata usia pasien adalah 40,2 tahun. Enam puluh tiga 72,4 pasien menderita asma dan rinitis alergik. Sebanyak 58 66,7 pasien asma persisten. Gambaran sensitisasi alergen TDR adalah 62,1 D. farinae; 51,7 D. pteronyssinus dan 48,3 B.tropicalis. Median kadar IgE spesifik secara bermakna lebih tinggi pada asma persisten dibandingkan asma intermiten untuk alergen D. farinae 1,30 vs. 0,0 kU/L; p=0,024 dan B. tropicalis 0,57 vs. 0,0 kU/L; p=0,015 . Kadar IgE spesifik D. pteronyssinus lebih tinggi pada asma persisten dibandingkan intermiten 0,67 vs. 0,00 kU/L; p=0,066.
Kesimpulan:Gambaran sensitisasi alergen secara berurutan didapatkan D. farinae 62,1, D. pteronyssinus 51,7 dan B. tropicalis 48,3 . Kadar IgE spesifik akibat sensitisasi D. farinae dan B. tropicalis lebih tinggi secara bermakna pada pasien asma persisten dibandingkan asma intermiten. Kadar IgE spesifik akibat sensitisasi D. pteronyssinus lebih tinggi pada pasien asma persisten dibandingkan asma intermiten, tetapi secara statistik tidak bermakna.

Introduction House dust mites HDM are an important inhalant allergen in allergic asthma. However, molecular diagnostic study using specific IgE level induced by HDM allergens associated with asthma severity has not been done in Indonesia.
Objective To investigate the difference of serum quantitative specific IgE levels induced by Dermatophagoides D. pteronyssinus, D. farinae and Blomia B. tropicalis sensitization in intermittent and persistent allergic asthma.
Method This was a cross sectional study on adult allergic asthma patients who were invited for serum specific IgE testing. This study was a part of a larger research within the Division of Allergy and Immunology, Cipto Mangunkusumo Hospital. Asthma severity was defined based on Global Initiative on Asthma GINA 2015 criteria and were grouped as intermittent or persistent. Quantitative specific IgE testing was done on blood serum using a multiple allergosorbent test Polycheck Allergy, Biocheck GmbH, Munster, Germany . The HDM allergens tested were D. pteronyssinus, D. farinae, and Blomia tropicalis. Difference between two groups were analyze using Mann Whitney test.
Results A total of 87 subjects were enrolled in this study 69 79.3 were women. Mean patients rsquo age was 40, 2 years. Sixty three 72.4 patients had asthma and allergic rhinitis. Fifty eight 66.7 patients were classified as persistent asthma. The prevalence of sensitization was 62.1 D. farinae, 51.7 D. pteronyssinus, and 48.3 Blomia tropicalis. The median of specific IgE levels is significantly higher in persistent asthma compares to intermittent asthma induced by D. farinae median 1.30 vs. 0.0 kU L p 0.024 and B. tropicalis median 0.57 vs. 0.0 kU L p 0.015 sensitization. Level of Specific IgE D. pteronyssinus is also to be higher in persistent asthma than the level measured in intermittent asthma 0.67 vs. 0.00 kU L p 0.066.
Conclusion Sensitization of HDM allergens is shown to be highest for D. farinae 62.1 , followed by D. pteronyssinus 51, 7 and Blomia tropicalis 48, 3 . Specific IgE level induced by D. farinae and Blomia tropicalis sensitization are significantly higher in patients with persistent compares to intermittent asthma, whereas specific IgE level induced by D. pteronyssinus sensitization to be higher in persistent asthma although not statistically significant."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2017
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
<<   1 2   >>